Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXCEL: Long-Term Safety of Febuxostat in Gout
NCT00175019Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2003
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of febuxostat in gout, sponsored by Takeda. Started Jul 2003; status: completed.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT00175019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175019.